| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -29 | -62 | 60 | -384 |
| Depreciation and amortization | 79 | 81 | 79 | 180 |
| Gain on sales of assets and businesses, net | NaN | 0 | 7 | 1 |
| Equity in earnings of affiliates, net | 6 | -16 | 7 | 16 |
| Loss on extinguishment of debt | -9 | -5 | NaN | NaN |
| Amortization of debt issuance costs and issue discounts | 3 | 2 | 3 | 6 |
| Deferred tax benefit | -11 | -4 | -16 | 84 |
| Asset-related charges | 1 | 5 | 16 | 11 |
| Stock-based compensation expense | 7 | 4 | 5 | 12 |
| Net periodic pension cost (income) | 0 | -1 | -1 | NaN |
| Defined benefit plan contributions | 1 | 0 | -6 | 8 |
| Other operating charges and credits, net | -14 | -1 | 5 | 14 |
| Accounts and notes receivable, net | 77 | -269 | -11 | 174 |
| Inventories and other current operating assets | -32 | 30 | 34 | 42 |
| Other non-current operating assets | -17 | 4 | -6 | -64 |
| Accounts payable | -58 | -86 | 8 | -87 |
| Other current operating liabilities | 12 | -95 | 9 | 83 |
| Other non-current operating liabilities | -8 | 38 | 3 | 239 |
| Cash used for operating activities | -44 | 137 | 146 | -19 |
| Purchases of property, plant, and equipment | 49 | 45 | 41 | 127 |
| Proceeds from life insurance policies | 1 | NaN | NaN | NaN |
| Proceeds from sales of assets and businesses | 7 | 0 | 6 | 1 |
| Foreign exchange contract settlements, net | 3 | -2 | 1 | 2 |
| Other investing activities | NaN | 0 | -1 | NaN |
| Cash used for investing activities | -44 | -43 | -35 | -128 |
| Proceeds from issuance of debt | 700 | 653 | 0 | 95 |
| Debt repayments | 689 | 668 | 8 | 111 |
| Payments on finance leases | 3 | 2 | 5 | 7 |
| Payments of debt issuance cost | 10 | 3 | 0 | 4 |
| Proceeds from supplier financing program | 16 | 16 | 17 | 47 |
| Payments to supplier financing program | 14 | 18 | 17 | 53 |
| Proceeds from exercised stock options, net | 2 | NaN | NaN | NaN |
| Payments related to tax withholdings on vested stock awards | 2 | 0 | 0 | 1 |
| Payments of dividends to the company's common shareholders | 13 | 15 | 13 | 50 |
| Other financing activities | NaN | 0 | 21 | NaN |
| Debt extinguishment payments | 6 | NaN | NaN | NaN |
| Cash used for financing activities | -19 | -37 | -5 | -84 |
| Effect of exchange rate changes on cash, cash equivalents, restricted cash and restricted cash equivalents | -2 | 2 | 6 | 21 |
| Decrease in cash, cash equivalents, restricted cash and restricted cash equivalents | -109 | 59 | 112 | -210 |
| Cash, cash equivalents, restricted cash and restricted cash equivalents at january 1, | 724 | 98 | 763 | NaN |
| Cash, cash equivalents, restricted cash and restricted cash equivalents at march 31, | 615 | 59 | 665 | NaN |
Chemours Co (CC)
Chemours Co (CC)